Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement
Education … Practice
Peer Review, Research
Publishing
Clinical Trials as Topic
R
Acupuncture Therapy
Acupuncture
Guidelines as Topic
United States
3. Good health
Guidelines and Guidance
Research Design
Practice Guidelines as Topic
Medicine
Humans
Controlled Clinical Trials as Topic
Periodicals as Topic
Quality of Health Care
DOI:
10.1089/acm.2010.1610
Publication Date:
2010-10-18T16:49:13Z
AUTHORS (7)
ABSTRACT
The Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) were published five journals 2001 and 2002. These guidelines, the form a checklist explanations use by authors journal editors, designed to improve reporting acupuncture trials, particularly interventions, thereby facilitating their interpretation replication. Subsequent reviews application impact STRICTA have highlighted value as well scope improvements revision. To manage revision process collaboration between Group, CONSORT Chinese Cochrane Centre was developed 2008. An expert panel with 47 participants convened that provided electronic feedback on revised draft checklist. At subsequent face-to-face meeting Freiburg, group 21 further planned dissemination. new checklist, which is an official extension CONSORT, includes six items 17 sub-items. set out guidelines rationale, details needling, treatment regimen, other components treatment, practitioner background, control or comparator interventions. In addition, part this process, each item been elaborated, examples good are provided. word "controlled" replaced "clinical," indicate applicable broad range clinical evaluation designs, including uncontrolled outcome studies case reports. It intended STRICTA, conjunction both main Statement nonpharmacologic will raise quality trials acupuncture.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (120)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....